# GINKGO BIOWORKS HOLDINGS INC (DNA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DNA/

- Reporting holders: 3
- Reported value: $218.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Boston Standard Wealth Management, LLC](https://holderbook.com/funds/1630939-boston-standard-wealth-management-llc/) | $194.6K | 15,165 | 0.0% | 3 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $17.2K | 1,338 | 0.0% | 5 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $6.3K | 489 | 0.0% | 9 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $218.0K |
| Q2 2026 | 185 | $402.4M |
| Q1 2026 | 173 | $201.9M |
| Q4 2025 | 182 | $284.9M |
| Q3 2025 | 180 | $480.0M |
| Q2 2025 | 170 | $411.6M |
| Q1 2025 | 166 | $193.7M |
| Q4 2024 | 168 | $356.1M |
| Q3 2024 | 156 | $244.2M |
| Q2 2024 | 6 | $1.0M |
| Q1 2024 | 4 | $3.0M |
| Q4 2023 | 3 | $6.0M |